Skip to Main Content
Welcome to the Scientist.com Marketplace

Go to Main Navigation

80210

FAP Fluorogenic Assay Kit

BPS Bioscience

DESCRIPTION

The FAP Fluorogenic Assay Kit is designed to measure FAP (fibroblast activation protein) protease activity for screening and profiling applications. It comes in a convenient 96-well format, with purified recombinant FAP enzyme (amino acids 29-760), DPP substrate, and DPP assay buffer for 100 enzyme reactions. The DPP fluorogenic substrate is incubated with a sample containing FAP enzyme to produce a fluorophore that can then be measured using a fluorescence reader.

DETAILS

  • Notes: The AMC standard is included so the researcher can quatitatively determine the specific activity of the enzyme using the AMC standard as a measure of how much AMC substrate was cleaved to release free AMC.
  • Uniprot: Q12884
  • Shiptemp: -80°C (dry ice)
  • Synonyms: Seprase, Prolyl endopeptidase FAP, 170 kDa melanoma membrane-bound gelatinase, Dipeptidyl peptidase FAP, Fibroblast activation protein alpha, FAPalpha, Gelatine degradation protease FAP, Integral membrane serine protease, Post-proline cleaving enzyme
  • Warnings: Avoid freeze/thaw cycles.
  • Category: Protease/Assay Kit
  • Background: Fibroblast Activation Protein, or FAP, is a type II membrane serine protease of the dipeptidyl peptidase (DPP) subfamily. It is involved in wound healing and tissue repair. FAP upregulation is seen on activated stromal fibroblasts present in cancer, including breast, lung, prostate, pancreatic and cervical cancer. It has an impact on the tumor microenvironment (TME), where it reduces the levels of PEDF (pigment epithelium derived factor), angiopoietin-1 and VEGF-c (vascular endothelial growth factor c) and increase TGF-β (transforming growth factor β) and create an immunosuppressive environment. It is used as biomarker for pro-tumorigenic stroma and links to a poor prognosis. Studies in animal models have shown that knock-out of FAP reduces the metastasis of pancreatic ductal adenocarcinomas (PDA). It has thus been proposed as a candidate target for small molecule inhibitors for cancer therapy applications. Additionally, its expression profile makes it a good candidate for CAR-T applications, with pre-clinical and clinical trials currently ongoing.
  • References: Pure E. and Blomberg R., 2018, Oncogene 37: 4343-4357. Bughda R., et al., 2021, Immunotargets Ther. 10:313-323.
  • Description: The FAP Fluorogenic Assay Kit is designed to measure FAP (fibroblast activation protein) protease activity for screening and profiling applications. It comes in a convenient 96-well format, with purified recombinant FAP enzyme (amino acids 29-760), DPP substrate, and DPP assay buffer for 100 enzyme reactions. The DPP fluorogenic substrate is incubated with a sample containing FAP enzyme to produce a fluorophore that can then be measured using a fluorescence reader.
  • Methodology: Fluorogenic
  • Supplied As: Supplied in a convenient 96-well format, with purified FAP enzyme, DPP substrate, and DPP assay buffer for 100 enzyme reactions.
  • Unspsc Code: 41105331
  • Unspsc Name: Protein chemifluorescent detection reagents or kits or substrates
  • Applications: Great for studying enzyme kinetics and screening small molecular inhibitors for drug discovery and HTS applications.
  • Product Type: Assay Kit
  • Biosafety Level: Not applicable (BSL-1)
  • Related Products: 80100
  • Contraindications: DMSO >1%, strong acids or bases, ionic detergents, high salt
  • Storage Stability: This assay kit will perform optimally for up to 6 months from date of receipt when the materials are stored as directed. Kit components require different storage conditions. Be sure to store each component at the proper temperature upon arrival.
  • Scientific Category: Protease
  • Instructions for Use: See assay kit datasheet for detailed protocol.